CARMA3 is overexpressed in human glioma and promotes cell invasion through MMP9 regulation in A172 cell line

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 149-154

  Feng, Xingjun ^a   Miao, Guozhuan ^a   Han, Yipeng ^a   Xu, Yi ^a  

^a GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

CARMA3; Glioma; Immunohistochemistry; MMP9

Indexed keywords

CASPASE RECRUITMENT DOMAIN CONTAINING MEMBRANE ASSOCIATED GUANYLATE KINASE PROTEIN 10; GELATINASE B; MATRIGEL; MESSENGER RNA; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASTROCYTE; BRAIN TISSUE; CANCER CELL CULTURE; CANCER GRADING; CELL INVASION; CELL INVASION ASSAY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEPLETION; STAINING; TUMOR CELL LINE; TUMOR GROWTH;

ADULT; CARD SIGNALING ADAPTOR PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM GRADING; NF-KAPPA B; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84893765082     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1018-2     Document Type: Article

References (24)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics. CA Cancer J Clin. 2012;62:10-29.
2. Fuller GN, Scheithauer BW. The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities. Brain Pathol. 2007;17:304-7.
3. Stupp R, Mason WP, van den Bent MJ, Weller M, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-96.
4. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:1061-8.
5. Gupta K, Salunke P. Molecular markers of glioma: an update on recent progress and perspectives. J Cancer Res Clin Oncol. 2012;138:1971-81.
6. Shahi MH, Schiapparelli P, Afzal M, Sinha S, et al. Expression and epigenetic modulation of sonic hedgehog-GLI1 pathway genes in neuroblastoma cell lines and tumors. Tumour Biol. 2011;32:113-27.
7. Yang L, Liu M, Gu Z, Chen J, et al. Overexpression of SASH1 related to the decreased invasion ability of human glioma U251 cells. Tumour Biol. 2012;33:2255-63.
8. Zhao T, Miao Z, Wang Z, Xu Y, et al., CARMA3 overexpression accelerates cell proliferation and inhibits paclitaxel-induced apoptosis through NF-kappaB regulation in breast cancer cells. Tumour Biol., 2013. doi:10.1007/s13277-013- 0869-x
9. Miao Z, Zhao T, Wang Z, Xu Y, et al. CARMA3 is overexpressed in colon cancer and regulates NF-kappaB activity and cyclin D1 expression. Biochem Biophys Res Commun. 2012;425:781-7.
10. Li Z, Qu L, Dong Q, Huang B, et al. Overexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progression. PLoS One. 2012;7:e36903.
11. Mahanivong C, Chen HM, Yee SW, Pan ZK, et al. Protein kinase C alpha-CARMA3 signaling axis links Ras to NF-kappa B for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells. Oncogene. 2008;27:1273-80.
12. Wang L, Guo Y, Huang WJ, Ke X, et al. Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappa B. J Biol Chem. 2001;276:21405-9.
13. McAllister-Lucas LM, Inohara N, Lucas PC, Ruland J, et al. Bimp1, a MAGUK family member linking protein kinase C activation to Bcl10-mediated NF-kappaB induction. J Biol Chem. 2001;276:30589-97.
14. Grabiner BC, Blonska M, Lin PC, You Y, et al. CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-{kappa}B activation. Genes Dev. 2007;21:984-96.
15. McAllister-Lucas LM, Ruland J, Siu K, Jin X, et al. CARMA3/Bcl10/MALT1- dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cells. Proc Natl Acad Sci USA. 2007;104:139-44.
16. Kim MS, Park MJ, Kim SJ, Lee CH, et al. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells. Int J Oncol. 2005;27:839-46.
17. Dong QZ, Wang Y, Tang ZP, Fu L, et al. Derlin-1 is overexpressed in non-small cell lung cancer and promotes cancer cell invasion via EGFR-ERK-mediated up-regulation of MMP-2 and MMP-9. Am J Pathol. 2013;182:954-64.
18. Jiang L, Wu J, Yang Y, Liu L, et al. Bmi-1 promotes the aggressiveness of glioma via activating the NF-kappaB/MMP-9 signaling pathway. BMC Cancer. 2012;12:406.
19. Sun J. CARMA3: a novel scaffold protein in regulation of NF-kappaB activation and diseases. World J Biol Chem. 2010;1:353-61.
20. McAllister-Lucas LM, Jin X, Gu S, Siu K, et al. The CARMA3-Bcl10-MALT1 signalosome promotes angiotensin II-dependent vascular inflammation and atherogenesis. J Biol Chem. 2010;285:25880-4.
21. Maity G, Choudhury PR, Sen T, Ganguly KK, et al. Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity. Tumour Biol. 2010;32:129-38.
22. Guo D, Zhou H, Wu Y, Zhou F, et al. Involvement of ERK1/2/NF-kappaB signal transduction pathway in TF/FVIIa/PAR2-induced proliferation and migration of colon cancer cell SW620. Tumour Biol. 2011;32:921-30.
23. Li H, Mittal A, Paul PK, Kumar M, et al. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: a potential role of MMP-9 in myopathy. J Biol Chem. 2009;284:4439-50.
24. Mendes Sdos S, Candi A, Vansteenbrugge M, Pignon MR, et al. Microarray analyses of the effects of NF-kappaB or PI3K pathway inhibitors on the LPS-induced gene expression profile in RAW264.7 cells: synergistic effects of rapamycin on LPS-induced MMP9-overexpression. Cell Signal. 2009;21:1109-22.